In cardiac myocytes, growth responses depend on activation of G protein-coupled receptors interacting with G(q/11) protein subfamily members. Endothelin receptors of the ETA subtype belong to this receptor group inducing hypertrophic responses. To understand the role of ETA receptors and signal transduction proteins in modulating cell growth, we analyzed the pharmacological profile of this receptor, its level of expression together with those of Galpha subunits and the RGS2 protein in cardiomyoblasts differentiating into the cardiac phenotype. H9c2 rat cardiomyoblasts were grown in the presence of 10% fetal bovine serum (FBS) or 1% FBS plus all-trans-retinoic acid to induce the cardiac phenotype. The pharmacological properties of ETA receptors were investigated by competition-binding experiments, whereas the protein expression profile was analyzed by immunoblot and immunocytochemistry. The pharmacological profile of ETA receptors changed during differentiation of cardiomyoblasts into cardiomyocytes, and the amount of expressed receptor appeared to increase. Immunocytochemistry also showed a marked increase of receptor expression on cell membranes of differentiated cardiomyocytes. Among the other signaling proteins examined, both Galpha(q/11) and RGS2 expression decreased in cells with the cardiac phenotype. Our results demonstrate that the expression of key proteins (ETA receptor, Galpha(q/11), and RGS2) involved in signal transduction of hypertrophic stimuli is modulated during cell differentiation and correlates with the cardiac phenotype.
|Autori:||Giusti L; Gargini C; Ceccarelli F; Bacci M; Italiani P; Mazzoni M|
|Titolo:||Modulation of endothelin-A receptor, G alpha subunit, and RGS2 expression during H9c2 cardiomyoblast differentiation|
|Anno del prodotto:||2004|
|Digital Object Identifier (DOI):||10.1081/LRST-200040331|
|Appare nelle tipologie:||1.1 Articolo in rivista|